Human death from bird flu: What is bird flu? Signs, treatments, precautions

A 59-year-old man in Mexico City who contracted a subtype of bird flu has died in Mexico City, the World Health Organization said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WSf8vw0
via IFTTT

Read More

Torrent Pharma inks licensing pact with Takeda to commercialise GERD drug

Torrent Pharmaceuticals on Wednesday said it has entered a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan in India. Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders gastroesophageal reflux disease.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/efJ1RhC
via IFTTT

Read More

Govt issues guidance paper to strengthen vaccine companies' reporting of adverse events

The new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthen their AE/AEFI (adverse events following immunisation) monitoring and reporting and pharmacovigilance department to ensure patient safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RQ5dJZD
via IFTTT

Read More

Organon appoints Vivek Soares as country lead for India, South Asia

US-based healthcare firm Organon announced Vivek Soares as the new country lead for India and South Asia, bringing over 20 years of biopharmaceutical experience. Soares, previously with Organon Thailand, will succeed Anjan Sen, pivotal in establishing Organon's India operations. Soares aims to drive growth in the region, working towards a healthier future for women.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Dxb9LAs
via IFTTT

Read More

US-based Zeda plans to raise up to $200 million for India foray

US-based Zeda Holdings plans to raise $200 million for its India expansion, led by CEO Shri Shetty. The company uses 3D printing for orthopaedic implants.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EuYBn79
via IFTTT

Read More

GSK blood cancer drug nearly halves risk of death in late-stage trial

In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with the steroid dexamethasone and pomalidomide were alive without their disease worsening at the end of a year. That compared with progression-free survival (PFS) of 51% of those who were treated with pomalidomide, dexamethasone and bortezomib. Pomalidomide is a generic version of Bristol Myers Squibb's Pomalyst, while bortezomib is the generic of Takeda Pharmaceuticals' Velcade.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NCa30OH
via IFTTT

Read More

Sun Pharma expects high single-digit top line growth in current fiscal

Sun Pharmaceutical Industries expects high single-digit top line growth in FY24 with total revenue at Rs 48,497 crore, led by Managing Director Dilip Shanghvi. The firm anticipates similar growth in FY25 with investments in product launches and R&D activities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dmnTsGo
via IFTTT

Read More